Inventor · disambiguated record
Hsiu-Kang Chang
Also filed as: CHANG HSIU-KANG
15 granted patents·2 pending applications·138 citations·filing 2000–2016
92Inventor score
Files withHEALTHBANKS BIOTECH CO LTD5THEVAX GENETICS VACCINE CO LTD5PURZER PHARMACEUTICAL CO LTD2REBER GENETICS CO LTD2CHANG HSIU-KANG1
Top patents by PatentIndex Score
17 records- 0188US7595054B2Fusion antigen used as vaccineHEALTHBANKS BIOTECH CO LTD·Filed 2007·Granted Sep 29, 2009·13 cites·42 claims
- 0287US9481714B2Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responsesTHEVAX GENETICS VACCINE CO LTD·Filed 2013·Granted Nov 1, 2016·11 cites·15 claims
- 0387US7465455B2Fusion protein of porcine reproductive and respiratory syndrome virus as PRRS vaccineHEALTHBANKS BIOTECH CO LTD·Filed 2006·Granted Dec 16, 2008·13 cites·20 claims
- 0486US8372407B2Chimeric HIV fusion proteins as vaccinesTHEVAX GENETICS VACCINE CO LTD·Filed 2012·Granted Feb 12, 2013·5 cites·12 claims
- 0584US8703411B2Cryopreservation of umbilical cord tissue for cord tissue-derived stem cellsCHANG HSIU-KANG·Filed 2011·Granted Apr 22, 2014·8 cites·16 claims
- 0684US7129619B2Ultrasonic nebulizer for producing high-volume sub-micron dropletsPURZER PHARMACEUTICAL CO LTD·Filed 2003·Granted Oct 31, 2006·65 cites·5 claims
- 0783US8206950B2Fusion antigen used as vaccine and method of making themLIAO CHAO-WEI·Filed 2008·Granted Jun 26, 2012·4 cites·11 claims
- 0881US9339536B2Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responsesTHEVAX GENETICS VACCINE CO LTD·Filed 2013·Granted May 17, 2016·5 cites·20 claims
- 0980US7618635B2Super-antigen fusion proteins and the use thereofHEALTHBANKS BIOTECH CO LTD·Filed 2005·Granted Nov 17, 2009·7 cites·8 claims
- 1073US10010602B2Vaccine compositions against porcine reproductive and respiratory syndrome and porcine circovirus associated diseasesREBER GENETICS CO LTD·Filed 2016·Granted Jul 3, 2018·4 cites·20 claims
- 1172US9676827B2Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responsesTHEVAX GENETICS VACCINE CO LTD·Filed 2016·Granted Jun 13, 2017·1 cites·20 claims
- 1271US9676826B2Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responsesTHEVAX GENETICS VACCINE CO LTD·Filed 2016·Granted Jun 13, 2017·1 cites·20 claims
- 1359US2009203884A1Chimeric hiv fusion proteins as vaccinesHEALTHBANKS BIOTECH CO LTD·Filed 2009·Application pending·0 cites
- 1450US6461592B1Method for transferring one or more active ingredients between different phase carriersPURZER PHARMACEUTICAL CO LTD·Filed 2000·Granted Oct 8, 2002·1 cites·18 claims
- 1543US2007243587A1Using a reverse genetic engineering platform to produce protein vaccines and protein vaccine of avian influenza virusHEALTHBANKS BIOTECH CO LTD·Filed 2007·Application pending·0 cites
- 1632US10172931B2Baculovirus display vectors and uses thereofREBER GENETICS CO LTD·Filed 2016·Granted Jan 8, 2019·0 cites·17 claims
- 1725US8771705B2Combination of protein vaccine and mesenchymal stem cells for treating cancerDENG WIN-PING·Filed 2010·Granted Jul 8, 2014·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Hsiu-Kang Chang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →